Over-expression of EDAG in the myeloid cell line 32D: Induction of GATA-1 expression and erythroid/megakaryocytic phenotype

Journal of Cellular Biochemistry

Volumn 110, Issue 4, 2010, Pages 866-874

  Ding, Ya Li ^a   Xu, Cheng Wang ^a   Wang, Zhi Dong ^a   Zhan, Yi Qun ^a,b   Li, Wei ^a   Xu, Wang Xiang ^a,b   Yu, Miao ^a,b   Ge, Chang Hui ^a   Li, Chang Yan ^a,b   Yang, Xiao Ming ^a,b,c  

^a BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^b State Key Laboratory of Proteomics   (China)

^c TIANJIN UNIVERSITY   (China)

Author keywords

EDAG; Erythroid megakaryocytic differentiation; GATA 1; Microarray

Indexed keywords

CD61 ANTIGEN; ERYTHROID KRUPPEL LIKE FACTOR; HEMOGLOBIN A; HEMOGLOBIN BETA CHAIN; PROTEIN; PROTEIN GFI 1B; PROTEIN GPIX; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR NF E2; TRANSCRIPTION FACTOR TAL1; UNCLASSIFIED DRUG; GATA1 PROTEIN, HUMAN; HEMGN PROTEIN, HUMAN; INTERLEUKIN 3; NUCLEAR PROTEIN;

ARTICLE; BONE MARROW CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; ERYTHROID CELL; ERYTHROID DIFFERENTIATION ASSOCIATED GENE; GENE; GENE OVEREXPRESSION; GENE REGULATORY NETWORK; HUMAN; HUMAN CELL; MEGAKARYOCYTE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; CYTOLOGY; DNA MICROARRAY; ERYTHROCYTE; FLOW CYTOMETRY; GENE SILENCING; GENETICS; K562 CELL LINE; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

CELL DIFFERENTIATION; ERYTHROCYTES; FLOW CYTOMETRY; GATA1 TRANSCRIPTION FACTOR; GENE SILENCING; HUMANS; INTERLEUKIN-3; K562 CELLS; MEGAKARYOCYTES; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; UP-REGULATION;

EID: 77954109419     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22597     Document Type: Article

References (28)

1. An LL, Li G, Wu KF, Ma XT, Zheng GG, Qiu LG, Song YH. 2005. High expression of EDAG and its significance in AML. Leukemia 19:1499-1502.
2. Bastian LS, Yagi M, Chan C, Roth GJ. 1996. Analysis of the megakaryocyte glycoprotein IX promoter identifies positive and negative regulatory domains and functional GATA and Ets sites. J Biol Chem 271:18554-18560.
3. Brecht K, Simonen M, Heim J. 2005. Upregulation of alpha globin promotes apoptotic cell death in the hematopoietic cell line FL5.12. Apoptosis 10:1043-1062. (Pubitemid 41285582)
4. Cantor AB, Orkin SH. 2002. Transcriptional regulation of erythropoiesis: An affair involving multiple partners. Oncogene 21:3368-3376.
5. Cayrol C, Lacroix C, Mathe C, Ecochard V, Ceribelli M, Loreau E, Lazar V, Dessen P, Mantovani R, Aguilar L, Girard JP. 2007. The THAP-zinc finger protein THAP1 regulates endothelial cell proliferation through modulation of pRB/E2F cell-cycle target genes. Blood 109:584-594.
6. Ceredig R, Rolink AG, Brown G. 2009. Models of haematopoiesis: Seeing the wood for the trees. Nat Rev Immunol 9:293-300.
7. Ferreira R, Ohneda K, Yamamoto M, Philipsen S. 2005. GATA1 function, a paradigm for transcription factors in hematopoiesis. Mol Cell Biol 25:1215-1227.
8. Green AR, DeLuca E, Begley CG. 1991. Antisense SCL suppresses self-renewal and enhances spontaneous erythroid differentiation of the human leukaemic cell line K562. EMBO J 10:4153-4158. (Pubitemid 21905447)
9. Iso T, Hamamori Y, Kedes L. 2003. Notch signaling in vascular development. Arterioscler Thromb Vasc Biol 23:543-553.
10. Kondo M, Wagers AJ, Manz MG, Prohaska SS, Scherer DC, Beilhack GF, Shizuru JA, Weissman IL. 2003. Biology of hematopoietic stem cells and progenitors: Implications for clinical application. Annu Rev Immunol 21:759-806.
11. Kroegel C, Yukawa T, Dent G, Venge P, Chung KF, Barnes PJ. 1989. Stimulation of degranulation from human eosinophils by platelet-activating factor. J Immunol 142:3518-3526. (Pubitemid 19137483)
12. Kulessa H, Frampton J, Graf T. 1995. GATA-1 reprograms avian myelomonocytic cell lines into eosinophils, thromboblasts, and erythroblasts. Genes Dev 9:1250-1262.
13. Layon ME, Ackley CJ, West RJ, Lowrey CH. 2007. Expression of GATA-1 in a non-hematopoietic cell line induces beta-globin locus control region chromatin structure remodeling and an erythroid pattern of gene expression. J Mol Biol 366:737-744.
14. Li CY, Zhan YQ, Xu CW, Xu WX, Wang SY, Lv J, Zhou Y, Yue PB, Chen B, Yang XM. 2004. EDAG regulates the proliferation and differentiation of hematopoietic cells and resists cell apoptosis through the activation of nuclear factor-kappa B. Cell Death Differ 11:1299-1308.
15. Li CY, Zhan YQ, Li W, Xu CW, Xu WX, Yu DH, Peng RY, Cui YF, Yang X, Hou N, Li YH, Dong B, Sun HB, Yang XM. 2007. Overexpression of a hematopoietic transcriptional regulator EDAG induces myelopoiesis and suppresses lymphopoiesis in transgenic mice. Leukemia 21:2277-2286.
16. Li CY, Fang F, Xu WX, Xu CW, Zhan YQ, Wang ZD, Ding YL, Li YH, Sun HB, Yang XM. 2008. Suppression of EDAG gene expression by phorbol 12-myristate 13-acetate is mediated through down-regulation of GATA-1. Biochim Biophys Acta 1779:606-615.
17. Lu J, Xu WX, Wang SY, Zhan YQ, Jiang Y, Cai WM, Yang XM. 2001. Isolation and characterization of EDAG-1, a novel gene related to regulation in hematopoietic system. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 33:641-646.
18. Lu J, Xu WX, Wang SY, Jiang Y, Li CY, Cai WM, Yang XM. 2002. Overexpression of EDAG-1 in NIH3T3 cells leads to malignant transformation. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 34:95-98. (Pubitemid 35216680)
19. Migliaccio G, Migliaccio AR, Kreider BL, Rovera G, Adamson JW. 1989. Selection of lineage-restricted cell lines immortalized at different stages of hematopoietic differentiation from the murine cell line 32D. J Cell Biol 109:833-841. (Pubitemid 19197041)
20. Nerlov C, Querfurth E, Kulessa H, Graf T. 2000. GATA-1 interacts with the myeloid PU.1 transcription factor and represses PU.1-dependent transcription. Blood 95:2543-2551. (Pubitemid 30210532)
21. Patel NS, Li JL, Generali D, Poulsom R, Cranston DW, Harris AL. 2005. Upregulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function. Cancer Res 65:8690-8697.
22. Pina C, May G, Soneji S, Hong D, Enver T. 2008. MLLT3 regulates early human erythroid and megakaryocytic cell fate. Cell Stem Cell 2:264-273.
23. Rylski M, Welch JJ, Chen YY, Letting DL, Diehl JA, Chodosh LA, Blobel GA, Weiss MJ. 2003. GATA-1-mediated proliferation arrest during erythroid maturation. Mol Cell Biol 23:5031-5042.
24. Valtieri M, Tocci A, Gabbianelli M, Luchetti L, Masella B, Vitelli L, Botta R, Testa U, Condorelli GL, Peschle C. 1998. Enforced TAL-1 expression stimulates primitive, erythroid and megakaryocytic progenitors but blocks the granulopoietic differentiation program. Cancer Res 58:562-569.
25. Williams CK, Li JL, Murga M, Harris AL, Tosato G. 2006. Up-regulation of the Notch ligand Delta-like 4 inhibits VEGF-induced endothelial cell function. Blood 107:931-939.
26. Yamaguchi Y, Zon LI, Ackerman SJ, Yamamoto M, Suda T. 1998. Forced GATA-1 expression in the murine myeloid cell line M1: Induction of c-Mpl expression and megakaryocytic/erythroid differentiation. Blood 91:450-457. (Pubitemid 28053366)
27. Yang LV, Nicholson RH, Kaplan J, Galy A, Li L. 2001. Hemogen is a novel nuclear factor specifically expressed in mouse hematopoietic development and its human homologue EDAG maps to chromosome 9q22, a region containing breakpoints of hematological neoplasms. Mech Dev 104:105-111.
28. Yang LV, Wan J, Ge Y, Fu Z, Kim SY, Fujiwara Y, Taub JW, Matherly LH, Eliason J, Li L. 2006. The GATA site-dependent hemogen promoter is transcriptionally regulated by GATA1 in hematopoietic and leukemia cells. Leukemia 20:417-425.